drug
varicella zoster vaccine
Marketedupdated 5mo agoby GlaxoSmithKline LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying varicella zoster vaccine
- phase1A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age
- phase2Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over
- phase2A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
- phase2A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
- phase4Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia
- phase3Shingrix in Renal Transplant Recipients
- phase1A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
- phase2Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above
News(4)
- GSK lays off 650 staffers amid closure of German vaccine manufacturing siteGSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid the pharma’s recent $2.5 billion savings campaign.biospace · 24d ago
- Even at big companies, health care costs are increasingTwo U.S. measles deaths, the profit motive for women's health, and more Morning Rounds news todaystat · 1mo ago
- Newer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ showsOxford researchers call shingles shot first vaccine protecting both heart and brain. Lower heart disease risk follows study showing reduced dementia risk.stat · 1mo ago
- STAT+: Shingles vaccine may lower dementia risk, new study findsNursing home residents who received at least one dose of shingles vaccine were 24 percent less likely to develop dementia, a new study found.stat · 3mo ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that